GlassScriptPrepare for your visit
Rhonda Gall
Gerontology (Nurse Practitioner) · Bowie, MD · NPI 1851795868
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$517.96
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Otsuka America Pharmaceutical, INC. $153.41
- Eisai INC. $114.06
- Smith+Nephew, INC. $70.05
- Neurocrine Biosciences, INC. $66.42
- Acadia Pharmaceuticals INC $64.02
- Sanofi-Aventis U.S. LLC $50.00
Drugs and devices associated with these payments
Rexulti
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Rhonda Gall listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10845451/rhonda-gall